Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study
Biomarker screening in mNSCLC patients in Türkiye was suboptimal compared to other countries, especially in public hospitals.
Authors
- Feyyaz Özdemir (ORCID: https://orcid.org/0000-0001-6980-2800)
- Mahmut Gümüş (ORCID: https://orcid.org/0000-0003-3550-9993)
- Çağatay Arslan (ORCID: https://orcid.org/0000-0002-3783-7432)
- Özgür Özyılkan (ORCID: https://orcid.org/0000-0001-8825-4918)
- Mehmet Alı Nahıt Şendur (ORCID: https://orcid.org/0000-0001-7021-6139)
- Nuri Karadurmuş (ORCID: https://orcid.org/0000-0003-3291-8062)
- İrfan Çiçin (ORCID: https://orcid.org/0000-0002-7584-3868)
- Umut Demırcı (ORCID: https://orcid.org/0000-0002-4833-6721)
- Erdem Göker (ORCID: https://orcid.org/0000-0001-6180-713X)
- Kaplan Ma (ORCID: https://orcid.org/0000-0003-0882-0524)
- Başak Oyan Uluç (ORCID: https://orcid.org/0000-0002-6623-6273)
- Bernadette Poellinger (ORCID: https://orcid.org/0009-0008-3495-3930)
- Mert Batum
- Sema Sezgin Göksu (ORCID: https://orcid.org/0000-0002-1222-0444)
- Yasemin Esen (ORCID: https://orcid.org/0009-0004-2047-6521)
- Muhammed Mustafa Oksuzokyar
- Milan van Rheenan
Institutions
- Dicle University (TR)
- Trakya University (TR)
- Izmir University (TR)
- Karadeniz Technical University (TR)
- Bilkent University (TR)
- Başkent University (TR)
- Akdeniz University (TR)
- Ege University (TR)
- Turkish Society of Hematology (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Memorial Ankara Hospital (TR)
- MSD (Germany) (DE)
- Başkent University Hospital (TR)
- MSD (Netherlands) (NL)
- Acıbadem Adana Hospital (TR)
- Istanbul Medeniyet University (TR)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1080/14796694.2025.2527477
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00